Pradaxa MDL Transferred to Judge Herndon (Southern District of Illinois)
Due to the large number of Pradaxa cases and likely hundreds more which we anticipate will be filed, a process has been established for consolidating the cases filed in the federal court system before a single judge for purposes of pre-trial discovery.
Attorneys from around the country, including Schlichter Bogard and Denton’s Roger Denton, presented oral argument before the Judicial Panel on Multi-District Litigation (“JPML”) in July. Roger Denton requested that these cases be filed or transferred to Southern District of Illinois before Chief Judge David Herndon. The Judicial Panel on Multi-District Litigation (“JPML”) entered an Order on August 8, 2012, agreeing with our firm’s request and assigned the cases to Judge Herndon. Judge Herndon will now be responsible for overseeing and coordinating all pre-trial discovery issues.
Attorneys at Schlichter Bogard & Denton represent individuals in the Pradaxa litigation. If you or someone you know has been injured by Pradaxa please contact the attorneys at Schlichter Bogard & Denton to discuss your case.
Typical injuries include the following:
• gastrointestinal bleeding
• kidney failure
• hemorrhagic stroke; and
• death (as a result of severe or excessive bleeding)
Please contact our experienced pharmaceutical drug attorneys for a free consultation.